GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a significant focus in healthcare studies, largely due to its remarkable impact on treating diseases such as second type diabetes and excess body fat. Ongoing research have revealed that more than glucose management, GLP-1 drugs offer benefits for cardiovascular funct